Update on C3 glomerulopathy: a complement-mediated disease F Caravaca-Fontán, L Lucientes, T Cavero, M Praga Nephron 144 (6), 272-280, 2020 | 66 | 2020 |
Mycophenolate mofetil in C3 glomerulopathy and pathogenic drivers of the disease F Caravaca-Fontán, MM Díaz-Encarnación, L Lucientes, T Cavero, ... Clinical Journal of the American Society of Nephrology 15 (9), 1287-1298, 2020 | 53 | 2020 |
The Factor H protein family: The switchers of the complement alternative pathway L Lucientes‐Continente, B Márquez‐Tirado, E Goicoechea de Jorge Immunological reviews 313 (1), 25-45, 2023 | 28 | 2023 |
Urinary soluble CD163 as a biomarker of disease activity and relapse in antineutrophil cytoplasm antibody-associated glomerulonephritis J Villacorta, L Lucientes, E Goicoechea, M Acevedo, T Cavero, ... Clinical Kidney Journal 14 (1), 212-219, 2021 | 18 | 2021 |
Factor H–related protein 1 drives disease susceptibility and prognosis in C3 glomerulopathy B Márquez-Tirado, J Gutiérrez-Tenorio, A Tortajada, LL Continente, ... Journal of the American Society of Nephrology 33 (6), 1137-1153, 2022 | 14 | 2022 |
C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies F Caravaca-Fontán, L Lucientes, N Serra, T Cavero, R Rodado, N Ramos, ... Nephrology Dialysis Transplantation 37 (11), 2128-2137, 2022 | 13 | 2022 |
Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis L Lucientes-Continente, G Fernández-Juárez, B Márquez-Tirado, ... Kidney International 105 (1), 177-188, 2024 | 3 | 2024 |
C3 glomerulopathy: an update on complement genetic drivers L Lucientes Continente, F Caravaca Fontan, J Gutierrez Tenorio, ... MOLECULAR IMMUNOLOGY 114, 493-493, 2019 | 1 | 2019 |
A NOVEL C3G-ASSOCIATED FHR-1 MUTANT PROTEIN PROVIDES INSIGHT INTO THE MOLECULAR BASIS OF COMPLEMENT DE-REGULATION J Gutierrez Tenorio, B Marquez Tirado, H Merinero, A Tortajada, E Arjona, ... MOLECULAR IMMUNOLOGY 114, 487-487, 2019 | 1 | 2019 |
ROLE OF FACTOR H AND ITS RELATED PROTEINS (FHR-1, FHR-2 FHR-5) IN ANCA-ASSOCIATED VASCULITIS: A GENETIC AND LONGITUDINAL SEROLOGICAL STUDY GM Fernandez Juarez, J Villacorta, L Lucientes, E Goicoechea De Jorge NEPHROLOGY DIALYSIS TRANSPLANTATION 37, I841-I841, 2022 | | 2022 |
FC075: Role of Factor H and its Related Proteins (FHR-1, FHR-2 FHR-5) in ANCA-Associated Vasculitis: A Genetic and Longitudinal Serological Study G Maria Fernandez Juarez, J Villacorta, L Lucientes, ... Nephrology Dialysis Transplantation 37 (Supplement_3), gfac113. 003, 2022 | | 2022 |
The influence of the complement alternative pathway in antineutrophil cytoplasmic antibody-associated vasculitis L Lucientes, J Villacorta Perez, G Fernandez Juarez, ... MOLECULAR IMMUNOLOGY 141, 226-227, 2022 | | 2022 |
Spanish Group for the Study of Glomerular Diseases GLOSEN: Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease (vol 15, pg 1287, 2020) F Caravaca-Fontan, MM Diaz-Encarnacion, L Lucientes, T Cavero, ... CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 15 (12), 1817-1817, 2020 | | 2020 |
The potential use of miRNAs as biomarkers in complement-mediated renal pathologies J Gutiérrez-Tenorio, F Caravaca, L Lucientes, A Llamas, B Marquez, ... Molecular Immunology 102, 158, 2018 | | 2018 |
Genetic and protein investigations of complement in anti-neutrophil cytoplasmic antibody-associated vasculitis LL Continente, JV Perez, J Gutierrez, F Diaz-Crespo, G Fernandez-Juarez, ... Molecular Immunology 102, 186, 2018 | | 2018 |
Characterization of complement components in a Spanish cohort of ANCA-associated vasculitis J Gutierrez-Tenorio, LL Continente, JV Pérez, BS Álamo, F Díaz-Crespo, ... Molecular Immunology 89, 116, 2017 | | 2017 |
MP076COMPREHENSIVE PROFILING OF THE COMPLEMENT SYSTEM IN ANCA ASSOCIATED VASCULITIS J Gutiérrez Tenorio, J Villacorta Pérez, L Lucientes Continente, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 32 (3), iii452-iii453, 2017 | | 2017 |